Barnesville, MD, United States of America

Paul S Meissner

USPTO Granted Patents = 14 


Average Co-Inventor Count = 2.7

ph-index = 3

Forward Citations = 98(Granted Patents)


Company Filing History:


Years Active: 1997-2004

Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents

Title: Paul S. Meissner: Innovator in Therapeutic Antibodies and Polypeptides

Introduction

Paul S. Meissner is a notable inventor based in Barnesville, MD (US), recognized for his significant contributions to the field of biotechnology. He holds a total of 14 patents, focusing primarily on therapeutic applications of polypeptides and antibodies. His work has implications for treating various medical conditions, including neurological and psychiatric disorders.

Latest Patents

Among his latest patents, Meissner has developed antibodies specific for human inositol monophosphatase H1. This invention includes a polynucleotide and DNA (RNA) encoding such polypeptides, along with a procedure for producing these polypeptides through recombinant techniques. The therapeutic applications of this invention involve screening and designing compounds capable of inhibiting hIMP-H1, as well as mapping genetic diseases. Additionally, he has disclosed methods for producing antibodies against hIMP-H1 polypeptides for therapeutic or diagnostic purposes. His work also includes antagonists against this polypeptide, which can be used to treat psychotic and depressive disorders. Furthermore, diagnostic assays for identifying mutations in nucleic acid sequences encoding the polypeptide have been developed.

Another significant patent involves transforming growth factor alpha HII polypeptides and the polynucleotides encoding them. This invention outlines a procedure for producing these polypeptides and their therapeutic uses, which include stimulating wound healing and treating various disorders such as neurological, ocular, kidney, and liver disorders. The patent also discusses antagonists against these polypeptides and their therapeutic applications in treating neoplasia, along with diagnostic assays for detecting altered levels of the polypeptide.

Career Highlights

Paul S. Meissner is currently associated with Human Genome Sciences, Inc., where he continues to innovate in the field of biotechnology. His extensive research and development efforts have positioned him as a key figure in the advancement of therapeutic solutions.

Collaborations

Throughout his career, Meissner has collaborated with notable colleagues, including Jeannine D. Gocayne and Wei Wu He. These collaborations have further enhanced the impact of his inventions in the scientific community.

Conclusion

Paul S. Meissner's contributions to biotechnology through his patents and research have paved the way for innovative therapeutic solutions. His work continues to influence the development of

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…